Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
126,235,733
-
Total 13F shares
-
226,659
-
Share change
-
+8,137
-
Total reported value
-
$289,925
-
Price per share
-
$1.28
-
Number of holders
-
13
-
Value change
-
+$135,650
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q3 2025
As of 30 Sep 2025,
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
226,659 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Apollon Wealth Management, LLC, Ground Swell Capital, LLC, Virtu Financial LLC, CITIGROUP INC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and NVWM, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.